PERIOD | PERFORMANCE |
---|---|
01.07.2023 - 01.07.2024 | 10,64% |
01.07.2022 - 01.07.2023 | -0,80% |
01.07.2021 - 01.07.2022 | 11,38% |
01.07.2020 - 01.07.2021 | 12,52% |
01.07.2019 - 01.07.2020 | 7,87% |
PERIOD | PERFORMANCE | YEARLY |
---|---|---|
1 Month | 4,08% | / |
3 Months | 1,89% | / |
6 Months | 10,77% | / |
Current year (YTD) | 10,77% | / |
1 year | 10,64% | / |
3 years | 21,49% | 6,70% |
5 year | 47,45% | 8,08% |
10 year | 120,12% | 8,21% |
Since inception | 283,39% | / |
PERIOD | PERFORMANCE |
---|---|
01.07.2023 - 01.07.2024 | 10,64% |
01.07.2022 - 01.07.2023 | -0,80% |
01.07.2021 - 01.07.2022 | 11,38% |
01.07.2020 - 01.07.2021 | 12,52% |
01.07.2019 - 01.07.2020 | 7,87% |
NAME | % OF FUNDVOLUME |
---|---|
ELI LILY & CO | 8,71% |
UNITEDHEALTH | 6,70% |
NOVO NORDISK | 5,69% |
MERCK & CO | 4,50% |
ASTRAZENECA | 4,03% |
ABBVIE | 3,60% |
ELEVANCE HEALTH | 3,59% |
BOSTON SCIENTIFIC | 3,51% |
INTUITIVE SURGICAL | 3,27% |
ROCHE HOLDING | 2,99% |
FUND | % OF FUNDVOLUME | |
---|---|---|
Stocks |
|
89,30% |
Open-end investment funds |
|
8,43% |
FUND | % OF FUNDVOLUME | |
---|---|---|
USA |
|
71,95% |
Denmark |
|
6,70% |
Switzerland |
|
5,80% |
Great Britain |
|
4,03% |
France |
|
2,04% |
Australia |
|
1,29% |
Japan |
|
1,10% |
South Korea |
|
1,04% |
Ireland |
|
0,83% |
Other |
|
2,95% |
FUND | % OF FUNDVOLUME | |
---|---|---|
Brand name drugs |
|
39,45% |
Medical equipment |
|
18,66% |
Biotechnology |
|
16,19% |
Medical services |
|
14,07% |
Life sciences tools&services |
|
7,95% |
Health care technology |
|
0,71% |
Generic drugs |
|
0,36% |
Other |
|
0,34% |